NanoVation Therapeutics
Drug Discovery · Cell & Gene Therapy
1open role
10+team · employees, estimated range
2020founded
13stories in the press
Overview
Enabling genetic medicines: We enable the safe, efficient delivery of gene therapies using LNP formulations customized by target, cargo and administration route.
Funding and backers
Team
11-50
employees, estimated range
Hiring now
1
+1 posted in 30 days
Momentum
13/100
hiring for its size
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2020
Founded
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
About Us We build the medicines we wish existed CPTx is a genetic medicines company redefining how we treat disease using immune-silent…
Instant Quantification of genetic modifications for Cell and Gene Therapies.
Benefits platform for cell and gene therapies designed to provide sustainable access to life-saving medicines.
Skyline Therapeutics is a fully integrated gene therapy company dedicated to the discovery, development and delivery of innovative…
Metagenomi is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for…
Capsida Biotherapeutics is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies…
Jobs
$59k – $67k per year · In office · Contractor · 5+ years exp · PhD · Vancouver
qPCR
Flow Cytometry
Apply
Salary insights
Compensation ranges based on this company's open jobs
Median
$68k
Typical range
$68k
Open positions
1
1
Jobs
Junior
100%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Junior | 1 | $68k | $68k |
Highest paying role
Scientist I, Preclinical-12 month contract
$68k
Normalized to USD per year
Growth
Hiring Momentum
29/100
Slowing
Open positions
1
0 opened / 1 closed in 30 days
Median time-to-fill
77 days
faster than 15% of the market
ATS activity
Every ~5 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Administrative
50% ▲
Science & Research
50% ▲
Activity Timeline
Added qPCR to stack
Oct 2026
Added Flow Cytometry to stack
Oct 2026
Tech stack
Technologies named in job postings at NanoVation Therapeutics over the last 12 months, by layer, with the share of postings for each.
Technologies in use
2
Postings analysed
1
Stack modernity
64/100
Practices & domains
Flow Cytometry
qPCR
Sign in to see how your skills match this stack
Sign In
News
NanoVation's ligand-free lcLNP achieves complete B cell depletion in NHP at 0.1 mg/kg
NanoVation's ligand-free lcLNP achieves complete B cell depletion in NHP at 0.1 mg/kg Most lipid nanoparticle (LNP) platforms face the same constraint: they are cleared rapidly by the liver, which makes it hard to deliver nucleic acids to tissues beyond t
Read more
Report
NanoVation wins "Deal of the Year" award from Life Sciences BC
News NanoVation wins "Deal of the Year" award from Life Sciences BC We're thrilled to share that NanoVation Therapeutics has been awarded the prestigious Deal of the Year award at the 27th Annual Life Sciences BC Awards! This recognition celebrates our pa
Read more
Report
NanoVation featured on Biotech TV
News NanoVation featured on Biotech TV NanoVation TherapeuticsTM was recently featured by the online media outlet Biotech TV, which interviewed company co-founders Drs Pieter Cullis and Jay Kulkarni. The host, BiotechTV founder Brad Loncar, opens the disc
Read more
Report
NanoVation Therapeutics: Funding Round Led By Convergent Ventures Completed
NanoVation Therapeutics, a company developing innovative technologies to overcome barriers to nucleic acid delivery, announced the expansion of its Board of Directors and the close of a funding round led by Convergent Ventures.
Read more
Report
NanoVation announces expansion of Board of Directors & completion of funding round led by Convergent Ventures
News NanoVation announces expansion of Board of Directors & completion of funding round led by Convergent Ventures Vancouver, British Columbia - November 19, 2024 -NanoVation Therapeutics, a platform company developing innovative technologies to overcome
Read more
Report
VIDEO: NanoVation CEO Dom Witzigmann at CLINAM 2023
Event VIDEO: NanoVation CEO Dom Witzigmann at CLINAM 2023 NanoVation Co-founder and CEO Dr. Dominik (Dom) Witzigmann presented on the topic of "Advancing lipid nanoparticles for safe and efficient nucleic acid delivery to extrahepatic tissues" at CLINAM 2
Read more
Report
NVTx leaders featured in ETPN webinar on next-generation LNP technologies
Event NVTx leaders featured in ETPN webinar on next-generation LNP technologies NanoVation TherapeuticsTM co-founders Drs Pieter Cullis and Dominik Witzigmann were among the featured speakers in the webinar "Next Generation LNP Technologies for Extra-Hepa
Read more
Report
ME Therapeutics Announces the Start of Testing of First mRNA Formulations from NanoVation Therapeutics Collaboration
Vancouver, British Columbia--(Newsfile Corp. - September 18, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field o
Read more
Report
NanoVation Therapeutics announces multi-target partnership with Novo Nordisk to develop genetic medicines targeting cardiometabolic and rare diseases
News NanoVation Therapeutics announces multi-target partnership with Novo Nordisk to develop genetic medicines targeting cardiometabolic and rare diseases NanoVation will receive research funding and is eligible to receive up to approximately US$600 milli
Read more
Report
NanoVation CSO featured on BIO Podcast
Event NanoVation CSO featured on BIO Podcast NanoVation Co-founder and CSO Dr. Jayesh Kulkarni was interviewed for the BIO Podcast at the BIO International Convention in San Diego, USA, in June 2024. He also spoke at the event on the topic "Exploring the
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Vancouver
Vancouver
Canada
HQ
2 open roles 2 posted in 90 days 50% engineering 10-50 est. staff $68k Avg Salary
hires for Science & Research, Early Careers